Suppr超能文献

用于恢复人类肠道微生物群失调的现代益生菌开发的最新进展

Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.

作者信息

Kumar Roshan, Sood Utkarsh, Gupta Vipin, Singh Mona, Scaria Joy, Lal Rup

机构信息

PhiXGen Private Limited, Gurugram, Haryana 122001 India.

2Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD USA.

出版信息

Indian J Microbiol. 2020 Mar;60(1):12-25. doi: 10.1007/s12088-019-00808-y. Epub 2019 May 25.

Abstract

A healthy gut is predominantly occupied by bacteria which play a vital role in nutrition and health. Any change in normal gut homeostasis imposes gut dysbiosis. So far, efforts have been made to mitigate the gastrointestinal symptoms using modern day probiotics. The majority of the probiotics strains used currently belong to the genera , , and . Recent advancements in culturomics by implementing newer techniques coupled with the use of gnotobiotic animal models provide a subtle ground to develop novel host specific probiotics therapies. In this review article, the recent advances in the development of microbe-based therapies which can now be implemented to treat a wide spectrum of diseases have been discussed. However, these probiotics are not classified as drugs and there is a lack of stringent law enforcement to protect the end users against the pseudo-probiotic products. While modern probiotics hold strong promise for the future, more rigorous regulations are needed to develop genuine probiotic products and characterize novel probiotics using the latest research and technology. This article also highlights the possibility of reducing antibiotic usage by utilizing probiotics developed using the latest concepts of syn and ecobiotics.

摘要

健康的肠道主要由细菌占据,这些细菌在营养和健康方面发挥着至关重要的作用。正常肠道内环境稳定的任何变化都会导致肠道生态失调。到目前为止,人们已努力使用现代益生菌来减轻胃肠道症状。目前使用的大多数益生菌菌株属于 、 、 和 属。通过采用更新技术结合使用悉生动物模型,文化组学的最新进展为开发新型宿主特异性益生菌疗法提供了微妙的基础。在这篇综述文章中,讨论了基于微生物的疗法的最新进展,这些疗法现在可用于治疗多种疾病。然而,这些益生菌未被归类为药物,并且缺乏严格的执法来保护终端用户免受伪益生菌产品的侵害。虽然现代益生菌对未来充满希望,但需要更严格的法规来开发真正的益生菌产品,并利用最新的研究和技术对新型益生菌进行表征。本文还强调了利用基于合生元和生态益生菌最新概念开发的益生菌来减少抗生素使用的可能性。

相似文献

1
Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.
Indian J Microbiol. 2020 Mar;60(1):12-25. doi: 10.1007/s12088-019-00808-y. Epub 2019 May 25.
2
The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
Life Sci. 2024 Apr 1;342:122535. doi: 10.1016/j.lfs.2024.122535. Epub 2024 Feb 24.
4
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
5
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
6
New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
Clin Infect Dis. 2015 May 15;60 Suppl 2(Suppl 2):S108-21. doi: 10.1093/cid/civ177.
8
Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Expert Rev Gastroenterol Hepatol. 2022 Apr;16(4):321-332. doi: 10.1080/17474124.2022.2056017. Epub 2022 Mar 22.
9
Gut microbiome-targeted therapies for Alzheimer's disease.
Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.
10
Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
J Ren Nutr. 2023 Nov;33(6S):S30-S39. doi: 10.1053/j.jrn.2022.12.004. Epub 2023 Aug 25.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application.
Front Med (Lausanne). 2025 Aug 1;12:1620079. doi: 10.3389/fmed.2025.1620079. eCollection 2025.
5
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases.
Molecules. 2025 Feb 4;30(3):687. doi: 10.3390/molecules30030687.
6
Role of Gut Microbiome in Cancer Treatment.
Indian J Microbiol. 2024 Sep;64(3):1310-1325. doi: 10.1007/s12088-024-01340-4. Epub 2024 Jun 27.
7
From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?).
Indian J Microbiol. 2024 Sep;64(3):810-820. doi: 10.1007/s12088-024-01267-w. Epub 2024 Apr 3.
8
Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases.
Microorganisms. 2024 Aug 2;12(8):1582. doi: 10.3390/microorganisms12081582.
9
Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators.
Antibiotics (Basel). 2024 Aug 1;13(8):720. doi: 10.3390/antibiotics13080720.
10
The role of in longevity and the future of probiotics.
Food Sci Biotechnol. 2024 Jul 11;33(9):2097-2110. doi: 10.1007/s10068-024-01631-y. eCollection 2024 Jul.

本文引用的文献

1
Chicken Gut Microbiome and Human Health: Past Scenarios, Current Perspectives, and Futuristic Applications.
Indian J Microbiol. 2020 Mar;60(1):2-11. doi: 10.1007/s12088-019-00785-2. Epub 2019 Feb 8.
2
Gut Microbial Dynamics during Conventionalization of Germfree Chicken.
mSphere. 2019 Mar 27;4(2):e00035-19. doi: 10.1128/mSphere.00035-19.
3
The urgent need for microbiology literacy in society.
Environ Microbiol. 2019 May;21(5):1513-1528. doi: 10.1111/1462-2920.14611. Epub 2019 Apr 11.
4
1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses.
Nat Biotechnol. 2019 Feb;37(2):179-185. doi: 10.1038/s41587-018-0008-8. Epub 2019 Feb 4.
5
A next generation probiotic, .
Crit Rev Food Sci Nutr. 2019;59(19):3227-3236. doi: 10.1080/10408398.2018.1517725. Epub 2018 Oct 29.
6
The Group: History and Health Related Applications.
Front Microbiol. 2018 Sep 10;9:2107. doi: 10.3389/fmicb.2018.02107. eCollection 2018.
7
Using bioreactors to study the effects of drugs on the human microbiota.
Methods. 2018 Oct 1;149:31-41. doi: 10.1016/j.ymeth.2018.08.003. Epub 2018 Aug 11.
8
Clinical translation of microbe-based therapies: Current clinical landscape and preclinical outlook.
Bioeng Transl Med. 2018 Jul 6;3(2):124-137. doi: 10.1002/btm2.10093. eCollection 2018 May.
9
Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome.
Cell Host Microbe. 2018 Jul 11;24(1):133-145.e5. doi: 10.1016/j.chom.2018.06.005.
10
with Functional Properties: An Approach to Increase Safety and Shelf-Life of Fermented Foods.
Biomed Res Int. 2018 May 28;2018:9361614. doi: 10.1155/2018/9361614. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验